Inhibition of Reovirus by Mycophenolic Acid is Associated with the M1 Genome Segment

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2004 May 28

PMID 15163710

Citations 15

Authors

Laura L Hermann

Kevin M Coombs

Affiliations

Soon will be listed here.

Abstract

Mycophenolic acid (MPA), an inhibitor of IMP dehydrogenase, inhibits reovirus replication and viral RNA and protein production. In mouse L929 cells, antiviral effects were greatest at 30 microg of MPA/ml. At this dosage, MPA inhibited replication of reovirus strain T3D more than 1,000-fold and inhibited replication of reovirus strain T1L nearly 100-fold, compared to non-drug-treated controls. Genetic reassortant analysis indicated the primary determinant of strain-specific differences in sensitivity to MPA mapped to the viral M1 genome segment, which encodes the minor core protein mu2. MPA also inhibited replication of both strains of reovirus in a variety of other cell lines, including Vero monkey kidney and U373 human astrocytoma cells. Addition of exogenous guanosine to MPA-treated reovirus-infected cells restored viral replicative capacity to nearly normal levels. These results suggest the mu2 protein is involved in the uptake and processing of GTP in viral transcription in infected cells and strengthens the evidence that the mu2 protein can function as an NTPase and is likely a transcriptase cofactor.

Citing Articles

Nanomolar concentrations of the photodynamic compound TLD-1433 effectively inactivate numerous human pathogenic viruses.

Coombs K, Glover K, Russell R, Kaspler P, Roufaiel M, Graves D Heliyon. 2024; 10(11):e32140.

PMID: 38882312 PMC: 11176859. DOI: 10.1016/j.heliyon.2024.e32140.

Therapeutic bacteria and viruses to combat cancer: double-edged sword in cancer therapy: new insights for future.

Yarahmadi A, Zare M, Aghayari M, Afkhami H, Jafari G Cell Commun Signal. 2024; 22(1):239.

PMID: 38654309 PMC: 11040964. DOI: 10.1186/s12964-024-01622-w.

Pharmacokinetic Model Analysis of Supralingual, Oral and Intravenous Deliveries of Mycophenolic Acid.

Gao X, Wu L, Tsai R, Ma J, Liu X, Chow D Pharmaceutics. 2021; 13(4).

PMID: 33920640 PMC: 8072905. DOI: 10.3390/pharmaceutics13040574.

Identification of Inhibitors of ZIKV Replication.

Morales Vasquez D, Park J, Avila-Perez G, Nogales A, de la Torre J, Almazan F Viruses. 2020; 12(9).

PMID: 32961956 PMC: 7551609. DOI: 10.3390/v12091041.

Calcium channel blockers reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatality.

Li H, Zhang L, Li S, Zhang S, Wan W, Zhang Y Cell Res. 2019; 29(9):739-753.

PMID: 31444469 PMC: 6796935. DOI: 10.1038/s41422-019-0214-z.

References

Dryden K, Farsetta D, Wang G, KEEGAN J, Fields B, Baker T . Internal/structures containing transcriptase-related proteins in top component particles of mammalian orthoreovirus. Virology. 1998; 245(1):33-46. DOI: 10.1006/viro.1998.9146. View

Keirstead N, Coombs K . Absence of superinfection exclusion during asynchronous reovirus infections of mouse, monkey, and human cell lines. Virus Res. 1998; 54(2):225-35. PMC: 7126977. DOI: 10.1016/s0168-1702(98)00023-9. View

Qiu T, Luongo C . Identification of two histidines necessary for reovirus mRNA guanylyltransferase activity. Virology. 2003; 316(2):313-24. DOI: 10.1016/j.virol.2003.08.027. View

Brentano L, Noah D, Brown E, Sherry B . The reovirus protein mu2, encoded by the M1 gene, is an RNA-binding protein. J Virol. 1998; 72(10):8354-7. PMC: 110211. DOI: 10.1128/JVI.72.10.8354-8357.1998. View

Robins M, Wnuk S, Yang X, Yuan C, Borchardt R, Balzarini J . Inactivation of S-adenosyl-L-homocysteine hydrolase and antiviral activity with 5',5',6',6'-tetradehydro-6'-deoxy-6'-halohomoadenosine analogues (4'-haloacetylene analogues derived from adenosine). J Med Chem. 1998; 41(20):3857-64. DOI: 10.1021/jm980163m. View

Neyts J, De Clercq E . Mycophenolate mofetil strongly potentiates the anti-herpesvirus activity of acyclovir. Antiviral Res. 1998; 40(1-2):53-6. DOI: 10.1016/s0166-3542(98)00047-3. View

Margolis D, Heredia A, Gaywee J, Oldach D, Drusano G, Redfield R . Abacavir and mycophenolic acid, an inhibitor of inosine monophosphate dehydrogenase, have profound and synergistic anti-HIV activity. J Acquir Immune Defic Syndr. 1999; 21(5):362-70. View

Williams R, LIVELY D, DELONG D, CLINE J, Sweeny M . Mycophenolic acid: antiviral and antitumor properties. J Antibiot (Tokyo). 1968; 21(7):463-4. DOI: 10.7164/antibiotics.21.463. View

Carter S, Franklin T, JONES D, LEONARD B, Mills S, Turner R . Mycophenolic acid: an anti-cancer compound with unusual properties. Nature. 1969; 223(5208):848-50. DOI: 10.1038/223848a0. View

10.

Mitsui A, Suzuki S . Immunosuppressive effect of mycophenolic acid. J Antibiot (Tokyo). 1969; 22(8):358-63. DOI: 10.7164/antibiotics.22.358. View

11.

Sidwell R, Huffman J, Khare G, Allen L, Witkowski J, ROBINS R . Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide. Science. 1972; 177(4050):705-6. DOI: 10.1126/science.177.4050.705. View

12.

Mizuno K, Tsujino M, Takada M, Hayashi M, Atsumi K . Studies on bredinin. I. Isolation, characterization and biological properties. J Antibiot (Tokyo). 1974; 27(10):775-82. DOI: 10.7164/antibiotics.27.775. View

13.

Luongo C, Contreras C, Farsetta D, Nibert M . Binding site for S-adenosyl-L-methionine in a central region of mammalian reovirus lambda2 protein. Evidence for activities in mRNA cap methylation. J Biol Chem. 1998; 273(37):23773-80. DOI: 10.1074/jbc.273.37.23773. View

14.

Kobashigawa J, Miller L, Renlund D, Mentzer R, Alderman E, Bourge R . A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators. Transplantation. 1998; 66(4):507-15. DOI: 10.1097/00007890-199808270-00016. View

15.

Gong Z, De Meyer S, Clarysse C, Verslype C, Neyts J, De Clercq E . Mycophenolic acid, an immunosuppressive agent, inhibits HBV replication in vitro. J Viral Hepat. 1999; 6(3):229-36. DOI: 10.1046/j.1365-2893.1999.00163.x. View

16.

Heredia A, Margolis D, Oldach D, Hazen R, Le N, Redfield R . Abacavir in combination with the inosine monophosphate dehydrogenase (IMPDH)-inhibitor mycophenolic acid is active against multidrug-resistant HIV-1. J Acquir Immune Defic Syndr. 2000; 22(4):406-7. DOI: 10.1097/00126334-199912010-00013. View

17.

Reinisch K, Nibert M, Harrison S . Structure of the reovirus core at 3.6 A resolution. Nature. 2000; 404(6781):960-7. DOI: 10.1038/35010041. View

18.

Mbisa J, Becker M, Zou S, Dermody T, Brown E . Reovirus mu2 protein determines strain-specific differences in the rate of viral inclusion formation in L929 cells. Virology. 2000; 272(1):16-26. DOI: 10.1006/viro.2000.0362. View

19.

Allison A, Eugui E . Mycophenolate mofetil and its mechanisms of action. Immunopharmacology. 2000; 47(2-3):85-118. DOI: 10.1016/s0162-3109(00)00188-0. View

20.

Sintchak M, Nimmesgern E . The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors. Immunopharmacology. 2000; 47(2-3):163-84. DOI: 10.1016/s0162-3109(00)00193-4. View